| Name | methyl brevifolincarboxylate | 
|---|---|
| Synonyms | 
                                
                                methyl 7,8,9-trihydroxy-3,5-dioxo-1,2,3,5-tetrahydrocyclopenta[c]isochromene-1-carboxylate
                                
                                
                                 Methyl brevifolincarboxylate methyl 7,8,9-trihydroxy-3,5-dioxo-1,2-dihydrocyclopenta[c]isochromene-1-carboxylate  | 
                        
| Description | Methyl brevifolincarboxylate (Brevifolincarboxylic acid methyl ester) is a potent influenza virus PB2 cap-binding inhibitor. Methyl brevifolincarboxylate exhibits inhibitory activity against influenza virus A/Puerto Rico/8/34 (H1N1) and A/Aichi/2/68 (H3N2) with IC50s of 27.16 μM and 33.41 μM. Anti-oxidant activity[1][2]. | 
|---|---|
| Related Catalog | |
| In Vitro | Methyl brevifolincarboxylate exhibits significant DPPH radical scavenging activity with an IC50 value of 8.9 μM. | 
| References | 
| Density | 1.78g/cm3 | 
|---|---|
| Boiling Point | 633.9ºC at 760mmHg | 
| Molecular Formula | C14H10O8 | 
| Molecular Weight | 306.22400 | 
| Flash Point | 245.9ºC | 
| Exact Mass | 306.03800 | 
| PSA | 134.27000 | 
| LogP | 0.75280 | 
| Vapour Pressure | 1.15E-16mmHg at 25°C | 
| Index of Refraction | 1.717 |